» Authors » Daniel Ferguson

Daniel Ferguson

Explore the profile of Daniel Ferguson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 1105
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
LaPoint A, Singer J, Ferguson D, Shew T, Renkemeyer M, Palacios H, et al.
J Clin Invest . 2024 Oct; 134(23). PMID: 39405118
Dysfunctional adipose tissue is believed to promote the development of hepatic steatosis and systemic insulin resistance, but many of the mechanisms involved are still unclear. Lipin 1 catalyzes the conversion...
2.
Tie M, Ferguson D, Chen Y, He A
Liver Int . 2024 Jun; 44(8):2091-2092. PMID: 38888257
No abstract available.
3.
Martino M, Habibi M, Ferguson D, Brookheart R, Thyfault J, Meyer G, et al.
Am J Physiol Endocrinol Metab . 2024 Feb; 326(4):E515-E527. PMID: 38353639
Exercise robustly increases the glucose demands of skeletal muscle. This demand is met by not only muscle glycogenolysis but also accelerated liver glucose production from hepatic glycogenolysis and gluconeogenesis to...
4.
Wu M, Tie M, Hu L, Yang Y, Chen Y, Ferguson D, et al.
Biochem Biophys Res Commun . 2024 Feb; 702:149655. PMID: 38340654
Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of liver disease worldwide. MTARC1, encoded by the MTARC1 gene, is a mitochondrial outer membrane-anchored enzyme. Interestingly, the...
5.
Yiew N, Deja S, Ferguson D, Cho K, Jarasvaraparn C, Jacome-Sosa M, et al.
iScience . 2023 Nov; 26(11):108196. PMID: 37942005
The liver coordinates the systemic response to nutrient deprivation and availability by producing glucose from gluconeogenesis during fasting and synthesizing lipids via lipogenesis (DNL) when carbohydrates are abundant. Mitochondrial pyruvate...
6.
Chan M, Daemen S, Beals J, Terekhova M, Yang B, Fu C, et al.
JHEP Rep . 2023 Oct; 5(11):100877. PMID: 37869071
Background & Aims: Metabolic dysfunction-associated fatty liver disease (MAFLD) is a common complication of obesity with a hallmark feature of hepatic steatosis. Recent data from animal models of MAFLD have...
7.
Martino M, Habibi M, Ferguson D, Brookheart R, Thyfault J, Meyer G, et al.
bioRxiv . 2023 Sep; PMID: 37662392
Exercise robustly increases the glucose demands of skeletal muscle. This demand is met not only by muscle glycogenolysis, but also by accelerated liver glucose production from hepatic glycogenolysis and gluconeogenesis...
8.
Han B, Chen Y, Song C, Chen Y, Chen Y, Ferguson D, et al.
Biochem Biophys Res Commun . 2023 Aug; 677:63-69. PMID: 37549603
The mammalian cell cycle is divided into four sequential phases, namely G1 (Gap 1), S (synthesis), G2 (Gap 2), and M (mitosis). Wee1, whose turnover is tightly and finely regulated,...
9.
Habibi M, Ferguson D, Eichler S, Chan M, LaPoint A, Shew T, et al.
bioRxiv . 2023 Feb; PMID: 36824926
Hepatic stellate cells (HSC) are non-parenchymal liver cells that produce extracellular matrix comprising fibrotic lesions in chronic liver diseases. Prior work demonstrated that mitochondrial pyruvate carrier (MPC) inhibitors suppress HSC...
10.
Yiew N, Deja S, Ferguson D, Cho K, Jarasvaraparn C, Jacome-Sosa M, et al.
bioRxiv . 2023 Feb; PMID: 36824879
The liver coordinates the systemic response to nutrient deprivation and availability by producing glucose from gluconeogenesis during fasting and synthesizing lipids via lipogenesis (DNL) when carbohydrates are abundant. Mitochondrial pyruvate...